Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Reliance Global Group Announces Formation of New Real Estate Division Aimed at Expanding Operations
-
NH TherAguix Announces the completion of Phase I Recruitment for the Pancreas Cohort and the entry into Phase II in the NANOSMART phase Ib/II trial.
-
PROFIT WARNING – DECREASE OF TURNOVER AND EBITDA
-
Invesco Ltd: Form 8.3 - Quanex Building Products Corportation
-
LightSolver Selected by Airbus and BMW Group as a Finalist in Quantum Computing Challenge
-
Tims China Announces Significant Financing from Founding Shareholders
-
TDC LAWSUIT NOTIFICATION: BFA Law Notifies Teradata Corp. (NYSE:TDC) Investors that the Company has been Sued for Securities Fraud, and Urges Investors to Contact Us
-
Invesco Ltd: Form 8.3 - DS Smith PLC
-
Inside information: Orion upgrades full-year outlook for 2024
-
Inside information: Orion and MSD Announce Mutual Exercise of Option Providing MSD Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castrat
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
SPT COURT DEADLINE APPROACHING: Sprout Social, Inc. (Nasdaq:SPT) Investors have Less Than 2 Weeks to Seek Lead in Securities Fraud Case; Contact BFA Law before Deadline
-
PWSC INVESTIGATION NOTIFICATION: BFA Law Notifies PowerSchool (NYSE:PWSC) Investors that it is Investigating the Potential Acquisition, and Urges Shareholders to Contact Us
-
Invesco Ltd: Form 8.3 - Bellway PLC
-
RPD INVESTIGATION NOTIFICATION: BFA Law Notifies Rapid7, Inc. (Nasdaq:RPD) Investors that it is Investigating the Potential Acquisition, and Urges Shareholders to Contact Us
-
PATH LAWSUIT NOTIFICATION: BFA Law Notifies UiPath, Inc. (NYSE:PATH) Investors that it has Sued the Company for Securities Fraud; Contact Us if You Lost Money
-
ELAN INVESTIGATION NOTICE: BFA Law Alerts Investors that it is Investigating Elanco (NYSE: ELAN) for Securities Fraud; Investors who Suffered Losses are Urged to Contact the Firm
-
UPDATE -- OKX Launches 'Compound Bonus' Campaign Featuring a 100,000 ARB Token Prize Pool
-
Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy
-
UPDATE -- OKX Launches 'Compound Bonus' Campaign Featuring a 100,000 ARB Token Prize Pool
-
Kraig Biocraft Laboratories Expands Facilities to Support Spider Silk Production Growth
-
NeuroStar® Launches Better Me Provider Program Nationwide
-
CRM INVESTIGATION NOTIFICATION: BFA Law Notifies Salesforce, Inc. (NYSE:CRM) Investors that it is Investigating Salesforce for Securities Fraud, Contact Us if You Lost Money
-
Business Update
-
Stellantis to Announce First Half 2024 Results on July 25
-
G1 Therapeutics Added to the Russell 2000® and 3000® Indexes
-
Spectral AI Joins Russell Microcap® Index
-
Recce Pharmaceuticals Reports Positive Data from Phase I/II Urinary Tract Infection (UTI) / Urosepsis Rapid Infusion Trial of RECCE® 327
-
"MOOD" by Brenae Acquired by Music Licensing, Inc.
-
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
-
Perma-Fix Environmental Services Added to Membership of Russell 3000 Index
-
Avatier Delivers Workforce-Driven Identity Management for IBM Z
-
Cross-industry Team Led by IPG Mediabrands, SeenThis and PubMatic Creates Climate Action Marketplace
-
Achieve Life Sciences Announces Addition to the U.S. Russell 3000® and Russell Microcap® Indexes
-
Halo Dental Technologies Wins Prestigious Red Dot Award for Design Concept 2024 with Innovative Halo Digital Mirror
-
Enphase Energy Releases its Solargraf Software Platform in the Netherlands
-
Heidelberg Materials Acquires Concrete Recycling & Materials Business in South Texas Market
-
Tonix Pharmaceuticals Awarded Up to $34 Million U.S. Department of Defense Contract for Accelerated Development of Broad-Spectrum Antiviral Program
-
CoreCivic Announces 2024 Second Quarter Earnings Release and Conference Call Dates
-
Syncromune Granted FDA Fast-Track Designation for SYNC-T SV-102 for the Treatment of Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
-
Humacyte Acellular Tissue Engineered Vessel (ATEV™) Receives FDA’s Regenerative Medicine Advanced Therapy (RMAT) Designation for Patients with Advanced Peripheral Artery Disease (PAD)
-
ARA at Forefront of Blast Effects and Brain Health Research
-
Connect Biopharma to Participate in the Leerink Partners I&I and Metabolism Therapeutics Forum
-
American Resources Corporation’s American Metals LLC Executes Business Combination with Nasdaq Listed AI Transportation Acquisition Corp
-
Ovid Therapeutics and Graviton Bioscience Announce Topline Data from a Phase 1 Clinical Trial Studying OV888/GV101 Capsule, a Potential First-In-Class Therapy for Cerebral Cavernous Malformations
-
Eos Energy Successfully Launches Commercial Production on First State-of-the-Art Manufacturing Line
-
TEN Ltd. NYSE Ticker Change to “TEN” Effective Today
-
Rush Street Interactive Crowned Customer Services Operator of the Year at 2024 EGR North America Awards
-
Lifecore Biomedical Announces Cooperation Agreement with 22NW
-
Japan’s APRESIA Systems Expands Access Network Solutions Portfolio with Integration of Infinera ICE-X Coherent Pluggables
